PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
13.87%
Revenue growth above 1.5x RUN's 8.10%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
29.38%
Gross profit growth 1.25-1.5x RUN's 23.49%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
510.02%
EBIT growth above 1.5x RUN's 62.98%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
150.57%
Operating income growth above 1.5x RUN's 62.98%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
314.88%
Net income growth above 1.5x RUN's 200.38%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
316.67%
EPS growth above 1.5x RUN's 198.02%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
300.00%
Diluted EPS growth above 1.5x RUN's 195.96%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.10%
Share reduction more than 1.5x RUN's 2.70%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
10.66%
Diluted share count expanding well above RUN's 4.60%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
90.53%
OCF growth above 1.5x RUN's 54.58%. David Dodd would confirm a clear edge in underlying cash generation.
68.62%
FCF growth above 1.5x RUN's 11.05%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-49.92%
Negative 10Y revenue/share CAGR while RUN stands at 319.97%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-21.54%
Negative 5Y CAGR while RUN stands at 122.43%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-18.17%
Negative 3Y CAGR while RUN stands at 62.17%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
88.61%
Positive long-term OCF/share growth while RUN is negative. John Neff would see a structural advantage in sustained cash generation.
84.07%
Positive OCF/share growth while RUN is negative. John Neff might see a comparative advantage in operational cash viability.
88.00%
Positive 3Y OCF/share CAGR while RUN is negative. John Neff might see a big short-term edge in operational efficiency.
290.88%
Below 50% of RUN's 615.79%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
300.31%
5Y net income/share CAGR similar to RUN's 276.94%. Walter Schloss might see both on parallel mid-term trajectories.
839.36%
3Y net income/share CAGR above 1.5x RUN's 301.76%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
-65.99%
Negative equity/share CAGR over 10 years while RUN stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-36.42%
Negative 5Y equity/share growth while RUN is at 336.60%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
373.90%
3Y equity/share CAGR 1.25-1.5x RUN's 295.00%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
18.10%
AR growth well above RUN's 0.93%. Michael Burry fears inflated revenue or higher default risk in the near future.
2.57%
Inventory shrinking or stable vs. RUN's 7.61%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
11.78%
Asset growth above 1.5x RUN's 4.31%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
35.07%
BV/share growth above 1.5x RUN's 0.37%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-5.16%
We’re deleveraging while RUN stands at 4.74%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-8.39%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-6.36%
We cut SG&A while RUN invests at 1.57%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.